Anavex Life Sciences Corporation (NASDAQ:AVXL) price closed lower on Friday, April 12, dropping -3.48% below its previous close.
A look at the daily price movement shows that the last close reads $4.45. The company’s 5Y monthly beta was ticking 0.57. Taking into account the 52-week price action we note that the stock hit a 52-week high of $10.45 and 52-week low of $4.17. The stock subtracted -20.17% on its value in the past month.
Anavex Life Sciences Corporation, which has a market valuation of $352.66 million, is expected to release its quarterly earnings report May 07, 2024 – May 13, 2024.
Revisions to the company’s EPS highlights a short term direction of a stock’s price movement, which in the last 7 days came up with no upward and no downward reviews. On the technical perspective front, indicators give AVXL a short term outlook of 100% Sell on average. Looking at the stock’s medium term indicators we note that it is averaging as a 100% Sell, while an average of long term indicators are currently assigning the stock as 100% Sell.
The overview shows that AVXL’s price is at present -9.52% off the SMA20 and -16.76% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 37.22, with weekly volatility standing at 4.51%. The indicator jumps to 5.45% when calculated based on the past 30 days. Anavex Life Sciences Corporation (NASDAQ:AVXL)’s beta value is holding at 0.59, while the average true range (ATR) indicator is currently reading 0.28. An analysis of the Anavex Life Sciences Corporation (NASDAQ:AVXL) stock in terms of its daily trading volume indicates that the 3-month average is 1.25 million.
Current records show that the company has 82.07M in outstanding shares. The insiders’ percentage holdings are 3.16% of outstanding shares while the percentage share held by institutions stands at 31.68%. But the -53.87% downside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
